Abstract
Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Current Pharmaceutical Biotechnology
Title:Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure
Volume: 13 Issue: 10
Author(s): M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue
Affiliation:
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Abstract: Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Export Options
About this article
Cite this article as:
D. Schwartz M., G. Hurst C., A. Kirk M., J.D. Reedy S. and H. Braue E., Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure, Current Pharmaceutical Biotechnology 2012; 13 (10) . https://dx.doi.org/10.2174/138920112802273191
DOI https://dx.doi.org/10.2174/138920112802273191 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of the Chemokines in Myocardial Ischemia and Reperfusion
Current Vascular Pharmacology Coronary Artery Disease and End-Stage Renal Disease - A Clinical Perspective
Current Hypertension Reviews Personality Disorders in a Cross-Cultural Perspective: Impact of Culture and Migration on Diagnosis and Etiological Aspects
Current Psychiatry Reviews Yeast as a Humanized Model Organism for Biotransformation-Related Toxicity
Current Drug Metabolism Ezetimibe and Vascular Endothelial Function
Current Vascular Pharmacology Editorial: Current Vision of Systemic Autoimmune Diseases - From Diagnosis to Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: Perspectives of Antiarrhythmic Therapy: New Trails, Challenges and Pitfalls)
Current Pharmaceutical Design Copy Number Variations with Isolated Fetal Ventriculomegaly
Current Molecular Medicine Structure and Sequence Based Analysis of Alpha-Amylase Evolution
Protein & Peptide Letters Organotypic Hippocampal Slice Cultures for Studies of Brain Damage, Neuroprotection and Neurorepair
Current Drug Targets - CNS & Neurological Disorders Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design Metabolic Syndrome in HIV-patients in Antiretroviral Therapy
Current HIV Research Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant State
Current Molecular Medicine Blood Pressure Management in Acute Stroke
Current Hypertension Reviews Effects of Cholinergic Enhancing Drugs on Cholinergic Transporters in the Brain and Peripheral Blood Lymphocytes of Spontaneously Hypertensive Rats
Current Alzheimer Research Basal Septal Hypertrophy
Current Cardiology Reviews High-pitch Dual-source CT Angiography before TAVI - the Value of ECG Gating
Current Medical Imaging Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions
Current Pharmaceutical Design Acid-Sensing Ion Channels: A Novel Therapeutic Target for Pain and Anxiety
Current Pharmaceutical Design